French biotech company Immusmol holds a 10-year expertise in the development of anti-hapten antibodies. The company validated a range of primary antibodies for small-molecule imaging in cell cultures and tissue samples. Furthermore, to enable multiplexed imaging of key neurotransmitters, including dopamine, serotonin, epinephrine, GABA, and glutamate, ImmuSmol created a dedicated immuno-staining kit: STAINperfect. Based on its range of anti-small molecule antibodies, ImmuSmol also offers ELISA kits for the detection of neurotransmitters, kynurenines, catecholamines, and arginine metabolites. All the products are made available worldwide to academic researchers and biotech companies through fast fedex shipping, and a network of distributors.